Association of HLA-DR and type II collagen autoimmunity with Meniere's disease

被引:25
作者
Koo, JW
Oh, SH
Chang, SO
Park, MH
Lim, MJ
Yoo, TJ
Kim, CS
机构
[1] Seoul Natl Univ, Coll Med, Dept Otolaryngol, Seoul 110744, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Clin Pathol, Seoul 110744, South Korea
[3] Univ Tennessee, Div Allergy & Immunol, Dept Med, Coll Med, Memphis, TN USA
来源
TISSUE ANTIGENS | 2003年 / 61卷 / 01期
关键词
autoimmunity; HLA-DR; Meniere's disease; rheumatoid arthritis; type; 2; collagen;
D O I
10.1034/j.1399-0039.2003.610112.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
To investigate HLA-associated genetic susceptibility to Meniere's disease in relation to type II collagen (CII) autoimmunity status, HLA-DRB1 genotyping and ELISA measurement of anti-CII antibody were performed in 41 Korean patients with Meniere's disease. In the anti-CII positive subgroup (20%) of patients, the frequency of HLA-DRB1*0405 was significantly increased (uncorrected) compared with both controls (63% vs 16%) and anti-CII negative patients (63% vs 12%). In the anti-CII negative subgroup, HLA-DRB1*1201 was significantly increased (uncorrected) (27% vs 10%) and DRB1*13 was decreased (6% vs 24%) compared with controls; these alleles appeared to confer susceptibility and resistance to the development of the disease. Association of HLA-DRB1*0405 with anti-CII positive Meniere's disease in this study suggests that it shares a specific HLA-DR sequence, QRRAA, as a genetic susceptibility factor with the anti-CII positive rheumatoid arthritis. In conclusion, whilst type II collagen autoimmunity may have a partial role in Meniere's disease, different HLA-DR alleles may also be associated with either susceptibility or resistance to the development of the disease in relation to anti-CII antibody status.
引用
收藏
页码:99 / 103
页数:5
相关论文
共 25 条
[1]   DISCRIMINATION OF HUMAN HLA-DRB1 ALLELES BY PCR-SSCP (SINGLE-STRAND CONFORMATION POLYMORPHISM) METHOD [J].
BANNAI, M ;
TOKUNAGA, K ;
LIN, L ;
KUWATA, S ;
MAZDA, T ;
AMAKI, I ;
FUJISAWA, K ;
JUJI, T .
EUROPEAN JOURNAL OF IMMUNOGENETICS, 1994, 21 (01) :1-9
[2]  
BIRGERSON L, 1987, AM J OTOL, V8, P323
[3]  
BROOKES GB, 1986, ARCH OTOLARYNGOL, V112, P536
[4]  
BUMM P, 1991, LARYNGO RHINO OTOL, V70, P260
[5]  
Cao MY, 1996, ANN OTO RHINOL LARYN, V105, P628
[6]   Myelin protein Po as a potential autoantigen in autoimmune inner ear disease [J].
Cao, MY ;
Dupriez, VJ ;
Rider, MH ;
Deggouj, N ;
Gersdorff, MCH ;
Rousseau, GG ;
Tomasi, JP .
FASEB JOURNAL, 1996, 10 (14) :1635-1640
[7]  
Cook AD, 1999, ARTHRITIS RHEUM, V42, P2569, DOI 10.1002/1529-0131(199912)42:12<2569::AID-ANR9>3.0.CO
[8]  
2-3
[9]   CORRELATION BETWEEN ANTIBODIES TO TYPE-II COLLAGEN AND TREATMENT OUTCOME IN BILATERAL PROGRESSIVE SENSORINEURAL HEARING-LOSS [J].
HELFGOTT, SM ;
MOSCISCKI, RA ;
MARTIN, JS ;
LORENZO, C ;
KIEVAL, R ;
MCKENNA, M ;
NADOL, J ;
TRENTHAM, DE .
LANCET, 1991, 337 (8738) :387-389
[10]  
HOLMDAHL R, 1989, CLIN EXP RHEUMATOL, V7, pS51